Bonginkosi Shozi

- Fellow
- Pronouns: He/Him/They
Biography
Dr Bonginkosi Shozi is currently a Fellow at the Sanford Law School’s Center for Law and the Biosciences. He is also an Honorary Research Fellow at the University of KwaZulu-Natal’s School of Law, affiliated with the Health Law and Ethics Research Interest Group. He holds the degrees the degrees of Bachelor of Laws (LLB); Master of Laws (LLM) in Constitutional Law, Theory and Human Rights Litigation; and Doctor of Philosophy (PhD) in Law — all obtained from the University of KwaZulu-Natal. Prior to joining Stanford Law School, he completed a two-year postdoctoral scholarship at the University of California San Diego’s Institute for Practical Ethics.
Dr Shozi’s research engages with legal and bioethical issues in the governance of novel human-health-related technologies at a global level, with a particular focus on developing world perspectives. His research has produced novel insights into non-Western perspectives on a number of cutting-edge technological areas, including genetic technologies, assisted reproductive technologies, and pharmaceuticals. He has authored academic works that have been featured in several prestigious international publications including the Journal of Law and the Biosciences, Bioethics, CRISPR Journal, Journal of Medical Ethics, the American Journal of Bioethics, and PLoS ONE. His academic works have research support from world-renowned institutions including the Royal Society and the National Institutes of Health.
In addition to his academic works, Dr Shozi has been heavily involved in various roles that are aimed at influencing policy at a global level, including as a member of the United Nations Office of the Special Adviser on Africa (UN-OSAA) African Knowledge Network consultative platform on intellectual property rights and; and as a board member of the Association for Responsible Research and Innovation in Genome Editing (ARRIGE).